KEGG: bci:BCI_0033
Several expression systems can be used to produce recombinant UPF0114 protein BCI_0033:
| Expression Host | Yield | Turnaround Time | Post-translational Modifications |
|---|---|---|---|
| E. coli | High | Short | Minimal |
| Yeast | High | Short-Medium | Some |
| Insect cells | Medium | Medium | More extensive |
| Mammalian cells | Variable | Long | Most comprehensive |
For optimal stability, the following storage conditions are recommended:
Long-term storage: Store at -20°C or -80°C in aliquots to prevent repeated freeze-thaw cycles
Working aliquots: Store at 4°C for up to one week
Reconstitution buffer: Tris/PBS-based buffer, pH 8.0, containing 6% trehalose
For extended storage: Add glycerol to a final concentration of 50%
Repeated freeze-thaw cycles should be avoided as they may lead to protein degradation and loss of activity . For reconstitution, it is recommended to briefly centrifuge the vial prior to opening and reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL .
When designing experiments to evaluate UPF0114 protein BCI_0033 function, researchers should follow these methodological steps:
Define clear variables: Identify independent variables (protein concentration, buffer conditions, potential binding partners) and dependent variables (binding affinity, structural changes, downstream effects)
Formulate specific hypotheses: Based on sequence analysis and structural predictions, develop testable hypotheses about the protein's function
Implement controls: Include both positive controls (well-characterized proteins from the same family) and negative controls (buffer-only or irrelevant protein controls)
Use a systematic approach: Employ multiple complementary techniques (biochemical assays, structural studies, interaction analyses) to build a comprehensive understanding
Control for extraneous variables: Account for factors such as protein batch variation, buffer composition differences, and experimental conditions that might affect results
This experimental design approach will help establish cause-effect relationships between the protein and observed phenomena while minimizing confounding variables .
When designing protein-protein interaction studies with UPF0114 protein BCI_0033, consider the following methodological approaches:
Selection of appropriate tags: While His-tagged versions of the protein are commonly available, evaluate whether the tag position (N- or C-terminal) affects binding interfaces
Binding assay selection: Choose from:
Pull-down assays using immobilized BCI_0033
Surface Plasmon Resonance (SPR) for real-time binding kinetics
Isothermal Titration Calorimetry (ITC) for thermodynamic parameters
Crosslinking followed by mass spectrometry for binding site identification
Control experiments:
Use tag-only controls to rule out tag-mediated interactions
Include concentration gradients to determine binding specificity
Perform competition assays with related proteins to assess selectivity
Experimental validation: Employ at least two independent techniques to confirm identified interactions, as each method has inherent limitations and biases
Variable manipulation: Systematically alter conditions (pH, ionic strength, temperature) to characterize the nature of the interaction
This structured approach enhances the reliability and validity of protein interaction findings .
Types of experimental controls to incorporate:
Negative controls:
Buffer-only samples to account for background signals
Unrelated proteins of similar size/properties to distinguish specific from non-specific effects
Denatured BCI_0033 to control for non-specific binding
Positive controls:
Well-characterized proteins from the same family
Known interacting partners of related proteins
Engineered variants with predicted functional alterations
Internal controls:
Multiple protein concentrations to establish dose-dependency
Time-course measurements to monitor reaction kinetics
Multiple batches of the protein to ensure reproducibility
Treatment controls:
Control selection should align with your experimental design type (between-subjects or within-subjects) and account for potential carryover effects in sequential tests . This methodical control implementation significantly reduces the risk of confounding variables influencing your results .
Advanced computational methods can provide valuable insights into UPF0114 protein BCI_0033 structure and function:
Structural prediction methodologies:
AlphaFold2/RoseTTAFold: For high-accuracy 3D structure prediction
Molecular dynamics simulations: To explore conformational dynamics
Homology modeling: Using related structures as templates
Threading approaches: For identifying structural homologs with low sequence similarity
Functional prediction approaches:
Gene ontology enrichment: Based on sequence homology and domain architecture
Protein-protein interaction prediction: Using methods like SPRING, PIPE, or STRING
Binding site prediction: Through CASTp, SiteMap, or FTSite
Transmembrane topology prediction: Using TMHMM or Phobius (particularly relevant given the hydrophobic regions in the sequence)
Integrative analysis:
Combine sequence conservation, physicochemical properties, and predicted structural features
Employ machine learning approaches that integrate multiple data types
Utilize evolutionary coupling analysis to identify co-evolving residues indicating functional importance
Validation approaches:
Cross-validation using multiple prediction algorithms
Comparison with experimental data from related proteins
Identification of conserved motifs or residues across the UPF0114 family
This multilayered computational approach can guide experimental design by generating testable hypotheses about structure-function relationships in UPF0114 protein BCI_0033 .
When encountering challenges with expression and purification of UPF0114 protein BCI_0033, implement this systematic troubleshooting approach:
Expression troubleshooting methodology:
Low expression yields:
Optimize codon usage for the host organism
Test multiple expression strains (BL21(DE3), Rosetta, etc. for E. coli)
Adjust induction parameters (temperature, inducer concentration, duration)
Consider alternate promoters or expression vectors
Test fusion partners that enhance solubility (SUMO, MBP, TRX)
Protein insolubility:
Reduce expression temperature (16-18°C)
Co-express with chaperones
Screen various lysis buffers with different detergents (for membrane proteins)
Implement on-column refolding techniques
Consider cell-free expression systems
Purification troubleshooting methodology:
Low binding efficiency to affinity resins:
Ensure tag accessibility (N vs. C-terminal positioning)
Optimize binding conditions (pH, salt concentration, imidazole)
Test alternate tag systems (His, GST, FLAG)
Use longer linkers between protein and tag
Protein aggregation during purification:
Add stabilizing agents (glycerol, trehalose, specific detergents)
Include reducing agents if cysteine residues are present
Optimize buffer composition and pH
Perform size exclusion chromatography at lower temperatures
Protein degradation:
Add protease inhibitors
Minimize purification time
Include EDTA (if compatible with your purification scheme)
Reduce purification temperature
This methodical approach helps identify specific bottlenecks in the expression and purification process, allowing for systematic optimization .
Post-translational modifications (PTMs) of UPF0114 protein BCI_0033 may vary depending on the expression system. Here's a comprehensive methodology for PTM analysis:
System-specific PTM analysis approaches:
| Expression System | Expected PTMs | Recommended Analysis Methods |
|---|---|---|
| E. coli | Minimal (mainly phosphorylation) | Phos-tag gels, LC-MS/MS with phospho-enrichment |
| Yeast | Phosphorylation, some glycosylation | LC-MS/MS, glycan staining, lectin affinity |
| Insect cells | Phosphorylation, O-glycosylation, some N-glycosylation | Glycosidase treatments, LC-MS/MS with ETD fragmentation |
| Mammalian cells | Full range of PTMs (phosphorylation, glycosylation, acetylation, etc.) | Multi-enzyme digestion, comprehensive LC-MS/MS |
Methodological workflow for PTM analysis:
Initial PTM screening:
Protein mobility shift assays (glycosylation, phosphorylation)
Staining with PTM-specific dyes (Pro-Q Diamond for phosphorylation, PAS for glycosylation)
Western blotting with PTM-specific antibodies
Mass spectrometry-based characterization:
Sample preparation with multiple proteases for improved coverage
Enrichment strategies for specific PTMs (TiO₂ for phosphopeptides, lectin affinity for glycopeptides)
Data-dependent acquisition with appropriate fragmentation methods (HCD, ETD, CID)
Targeted analysis of predicted modification sites
Functional validation of identified PTMs:
Site-directed mutagenesis of modified residues
Expression in systems with different PTM capabilities
Inhibitor studies to block specific modifications
Comparison of differentially modified protein activity
This systematic approach allows comprehensive characterization of PTMs in UPF0114 protein BCI_0033 expressed in different systems, providing insights into how these modifications might affect protein structure and function .
When faced with contradictory results in UPF0114 protein BCI_0033 studies, implement this systematic resolution methodology:
Analytical verification steps:
Protein identity confirmation: Verify protein sequence by mass spectrometry
Structural integrity assessment: Evaluate protein folding using circular dichroism or thermal shift assays
Batch-to-batch comparison: Test multiple protein preparations in parallel
Tag interference evaluation: Compare tagged versus untagged versions or different tag positions
Experimental design evaluation:
Variable identification: Catalog all variables between contradictory experiments
Controlled replication: Systematically modify single variables to identify sources of discrepancy
Blinded analysis: Implement blinded data collection and analysis to reduce bias
Statistical reassessment: Review statistical methods, sample sizes, and power calculations
Cross-validation approaches:
Orthogonal methods: Employ alternative techniques that measure the same parameter
Collaborative verification: Engage independent laboratories for confirmation
Positive control validation: Ensure positive controls behave as expected across all experimental conditions
Reconciliation strategies:
Context-dependency mapping: Define specific conditions where each result occurs
Mechanistic investigation: Formulate hypotheses explaining how contradictory results might reflect different aspects of protein function
Integrated model development: Create models incorporating apparently contradictory data into a cohesive framework
This systematic approach helps distinguish between genuine biological complexity and technical artifacts in contradictory results .
Analyzing the membrane association properties of UPF0114 protein BCI_0033 requires specialized methodological considerations:
Prediction-based analysis:
Hydropathy analysis: The amino acid sequence "MNKIIEKMIYESRWLLFPVYIGLSFGFILLTLKFFHEIIQFLPKIFDMPESDLILIVLSM IDIALVGGLLVMVMFSGYENFILKMSDDCNQKRLNWMGKMDVNSIKNKVASSIVAISSVH LLRIFMEADRTRDNKIMWCVIIHLAFVLSAFGMAYIDKMSKTKS" contains hydrophobic stretches consistent with potential membrane association
Topology prediction: Use algorithms like TMHMM, Phobius, or TOPCONS to predict transmembrane regions and orientation
Comparative analysis: Assess membrane association patterns of homologous UPF0114 family proteins
Experimental verification methods:
Membrane fractionation: Sequential ultracentrifugation to separate cellular compartments
Carbonate extraction: Distinguish peripheral from integral membrane proteins
Protease protection assays: Determine protein topology and exposed domains
Fluorescence microscopy: Using tagged versions to visualize cellular localization
Reconstitution approaches:
Liposome binding assays: Test association with artificial membranes of defined composition
Nanodiscs: Study protein behavior in a more native-like membrane environment
Detergent screening: Identify optimal solubilization conditions for structural and functional studies
Structural studies in membrane mimetics:
NMR with detergent micelles: For high-resolution structural information
Cryo-EM: For structural determination in larger membrane mimetics
FTIR spectroscopy: To assess secondary structure in membrane environments
This comprehensive approach enables reliable characterization of the membrane association properties of UPF0114 protein BCI_0033, critical for understanding its biological function .
To systematically investigate the evolutionary significance of UPF0114 protein BCI_0033, implement this comprehensive methodological framework:
Phylogenetic analysis methodology:
Homolog identification: BLAST searches across diverse taxonomic groups
Multiple sequence alignment: Using MUSCLE, MAFFT, or T-Coffee algorithms
Tree construction: Maximum likelihood, Bayesian, and distance-based methods
Tree validation: Bootstrap analysis and comparison of tree topologies from different methods
Evolutionary pressure analysis:
dN/dS ratio calculation: To identify positions under purifying or positive selection
Conservation scoring: Using methods like ConSurf to map conservation onto predicted structures
Evolutionary trace analysis: To identify functionally important residues
Coevolutionary analysis: Identifying co-evolving residue networks suggesting functional linkages
Comparative genomics approaches:
Synteny analysis: Examining gene neighborhood conservation
Gene fusion events: Identifying domains that have fused with UPF0114 in different lineages
Horizontal gene transfer assessment: Evaluating phylogenetic incongruencies
Gene loss patterns: Mapping taxonomic distribution and loss events
Structural evolution investigation:
Ancestral sequence reconstruction: Inferring and characterizing ancestral forms
Structural comparison: Mapping sequence changes onto structural models
Domain architecture analysis: Tracking domain gain/loss events across evolution
Function prediction: Using evolutionary patterns to infer potential functions
This systematic evolutionary analysis can provide insights into the functional importance of UPF0114 protein BCI_0033, its adaptation in different organisms, and functional conservation or divergence patterns across species .
State-of-the-art methodological approaches for determining the structure of UPF0114 protein BCI_0033 include:
This multi-technique approach provides complementary structural information and higher confidence in the determined structure of UPF0114 protein BCI_0033 .
To comprehensively identify and characterize binding partners of UPF0114 protein BCI_0033, implement these methodological approaches:
Unbiased interaction discovery methods:
Targeted interaction validation techniques:
Surface plasmon resonance (SPR): For binding kinetics and affinity
Microscale thermophoresis (MST): For interactions in solution
Isothermal titration calorimetry (ITC): For thermodynamic parameters
FRET/BRET assays: For interactions in cellular contexts
Structural characterization of complexes:
Cryo-EM of complexes: For visualization of interaction interfaces
Hydrogen-deuterium exchange MS: To map binding surfaces
Cross-linking MS: To identify residues in proximity
NMR chemical shift mapping: For identifying interaction surfaces
Functional validation approaches:
Mutagenesis of predicted interface residues: To disrupt specific interactions
Competition assays: To determine binding specificity
Cellular co-localization studies: For physiological relevance
Functional readouts: Measuring effects of disrupting interactions
Computational integration:
Network analysis: Placing identified interactions in broader cellular contexts
Molecular docking: Predicting binding modes of validated partners
Integrated scoring approaches: Combining multiple lines of evidence
This comprehensive interactomics strategy enables reliable identification and characterization of physiologically relevant binding partners of UPF0114 protein BCI_0033 .
For investigating the physiological role of UPF0114 protein BCI_0033 in bacterial systems, implement these experimental design approaches:
Genetic manipulation studies:
Gene knockout/knockdown: Using CRISPR interference or homologous recombination
Controlled expression systems: For titrated overexpression or complementation
Functional complementation: Testing if BCI_0033 can rescue phenotypes in related bacterial systems
Point mutants: Creating variants with altered predicted functional residues
Phenotypic characterization designs:
Growth curve analysis: Under various stress conditions (pH, temperature, osmotic pressure)
Membrane integrity tests: Using fluorescent dyes to assess permeability
Metabolomic profiling: To identify altered metabolic pathways
Transcriptomic response: RNA-seq to identify affected pathways
Localization and dynamics studies:
Fluorescent protein fusions: To track subcellular localization
FRAP analysis: To measure protein mobility
Super-resolution microscopy: For precise spatial organization
Time-lapse imaging: Under changing environmental conditions
Interaction with membrane components:
Lipid binding assays: To identify preferred membrane compositions
Detergent resistance: As measure of membrane microdomain association
Membrane potential measurements: To assess effects on membrane energetics
Ion flux measurements: To test potential transport functions
Comparative system analysis:
Multi-species phenotyping: Testing effects in different bacterial backgrounds
Heterologous expression: Expression of BCI_0033 in model organisms
Environmental response profiling: Under conditions mimicking natural habitat
In vivo competition assays: Between wild-type and mutant strains
These experimental design approaches provide a comprehensive framework for elucidating the physiological role of UPF0114 protein BCI_0033 in bacterial systems, following true experimental design principles of variable manipulation, randomization, and controlled observation .